Estrogen-induced porphyria cutanea tarda. Report of three cases.
D000328:Adult; D000368:Aged; D000434:Alcoholic Beverages; D002741:Chlorotrianisene / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004054:Diethylstilbestrol / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006454:Hemoglobins; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000503:physiopathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009641:Norethynodrel / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011164:Porphyrias / Q000139:chemically induced* / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D011166:Porphyrins / Q000097:blood / Q000652:urine; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013448:Sulfobromophthalein
D003276:Contraceptives, Oral; D004967:Estrogens; D006454:Hemoglobins; D011166:Porphyrins; D013448:Sulfobromophthalein; D002741:Chlorotrianisene; D004054:Diethylstilbestrol; D009641:Norethynodrel